This 2018 interventional clinical study compared the effectiveness of oral versus intravenous (IV) magnesium supplementation in preventing hypomagnesemia and arrhythmias following coronary artery bypass grafting (CABG). Eighty-two patients were randomized to receive either 1,600 mg of oral magnesium hydroxide via nasogastric tube before surgery or 2 g of IV magnesium